Global Gastro Esophageal Reflux Disease (GERD) Drug Market Research Report 2023

Report ID: 1893169 | Published Date: Jan 2025 | No. of Page: 98 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Gastro Esophageal Reflux Disease (GERD) Drug Market Overview
    1.1 Product Overview and Scope of Gastro Esophageal Reflux Disease (GERD) Drug
    1.2 Gastro Esophageal Reflux Disease (GERD) Drug Segment by Type
        1.2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 H2 Receptor Antagonist
        1.2.3 Proton Pump Inhibitor (PPi)
        1.2.4 Antacids
    1.3 Gastro Esophageal Reflux Disease (GERD) Drug Segment by Application
        1.3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Comparison by Application: (2022-2028)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Medical Center
        1.3.5 Others
    1.4 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size Estimates and Forecasts
        1.4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue 2017-2028
        1.4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales 2017-2028
        1.4.3 Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Region: 2017 Versus 2021 Versus 2028
2 Gastro Esophageal Reflux Disease (GERD) Drug Market Competition by Manufacturers
    2.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Sites, Area Served, Product Type
    2.5 Gastro Esophageal Reflux Disease (GERD) Drug Market Competitive Situation and Trends
        2.5.1 Gastro Esophageal Reflux Disease (GERD) Drug Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Gastro Esophageal Reflux Disease (GERD) Drug Players Market Share by Revenue
        2.5.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gastro Esophageal Reflux Disease (GERD) Drug Retrospective Market Scenario by Region
    3.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
        3.3.1 North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
        3.3.2 North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country
        3.3.3 U.S.
        3.3.4 Canada
    3.4 Europe Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
        3.4.1 Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
        3.4.2 Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Region
        3.5.1 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region
        3.5.2 Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
        3.5.12 Philippines
        3.5.13 Vietnam
    3.6 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
        3.6.1 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
        3.6.2 Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Market Facts & Figures by Country
        3.7.1 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country
        3.7.2 Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 U.A.E
4 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Analysis by Type
    4.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2022)
    4.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Type (2017-2022)
    4.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2017-2022)
5 Global Gastro Esophageal Reflux Disease (GERD) Drug Historic Market Analysis by Application
    5.1 Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2022)
    5.2 Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Application (2017-2022)
    5.3 Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Pfizer
        6.1.1 Pfizer Corporation Information
        6.1.2 Pfizer Description and Business Overview
        6.1.3 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
        6.1.5 Pfizer Recent Developments/Updates
    6.2 Novartis AG
        6.2.1 Novartis AG Corporation Information
        6.2.2 Novartis AG Description and Business Overview
        6.2.3 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
        6.2.5 Novartis AG Recent Developments/Updates
    6.3 GlaxoSmithKline
        6.3.1 GlaxoSmithKline Corporation Information
        6.3.2 GlaxoSmithKline Description and Business Overview
        6.3.3 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
        6.3.5 GlaxoSmithKline Recent Developments/Updates
    6.4 Merck
        6.4.1 Merck Corporation Information
        6.4.2 Merck Description and Business Overview
        6.4.3 Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Merck Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
        6.4.5 Merck Recent Developments/Updates
    6.5 Medtronic
        6.5.1 Medtronic Corporation Information
        6.5.2 Medtronic Description and Business Overview
        6.5.3 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
        6.5.5 Medtronic Recent Developments/Updates
    6.6 The Kroger Co.
        6.6.1 The Kroger Co. Corporation Information
        6.6.2 The Kroger Co. Description and Business Overview
        6.6.3 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
        6.6.5 The Kroger Co. Recent Developments/Updates
    6.7 Aros Pharma
        6.6.1 Aros Pharma Corporation Information
        6.6.2 Aros Pharma Description and Business Overview
        6.6.3 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
        6.7.5 Aros Pharma Recent Developments/Updates
    6.8 AstraZeneca, Plc.
        6.8.1 AstraZeneca, Plc. Corporation Information
        6.8.2 AstraZeneca, Plc. Description and Business Overview
        6.8.3 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
        6.8.5 AstraZeneca, Plc. Recent Developments/Updates
    6.9 Addex Therapeutics
        6.9.1 Addex Therapeutics Corporation Information
        6.9.2 Addex Therapeutics Description and Business Overview
        6.9.3 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
        6.9.5 Addex Therapeutics Recent Developments/Updates
    6.10 Takeda Pharmaceutical Company Limited
        6.10.1 Takeda Pharmaceutical Company Limited Corporation Information
        6.10.2 Takeda Pharmaceutical Company Limited Description and Business Overview
        6.10.3 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product Portfolio
        6.10.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
7 Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Cost Analysis
    7.1 Gastro Esophageal Reflux Disease (GERD) Drug Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Gastro Esophageal Reflux Disease (GERD) Drug
    7.4 Gastro Esophageal Reflux Disease (GERD) Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Gastro Esophageal Reflux Disease (GERD) Drug Distributors List
    8.3 Gastro Esophageal Reflux Disease (GERD) Drug Customers
9 Gastro Esophageal Reflux Disease (GERD) Drug Market Dynamics
    9.1 Gastro Esophageal Reflux Disease (GERD) Drug Industry Trends
    9.2 Gastro Esophageal Reflux Disease (GERD) Drug Market Drivers
    9.3 Gastro Esophageal Reflux Disease (GERD) Drug Market Challenges
    9.4 Gastro Esophageal Reflux Disease (GERD) Drug Market Restraints
10 Global Market Forecast
    10.1 Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Gastro Esophageal Reflux Disease (GERD) Drug by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Gastro Esophageal Reflux Disease (GERD) Drug by Type (2023-2028)
    10.2 Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Gastro Esophageal Reflux Disease (GERD) Drug by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Gastro Esophageal Reflux Disease (GERD) Drug by Application (2023-2028)
    10.3 Gastro Esophageal Reflux Disease (GERD) Drug Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Gastro Esophageal Reflux Disease (GERD) Drug by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Gastro Esophageal Reflux Disease (GERD) Drug by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
    Table 2. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
    Table 3. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) of Key Manufacturers (2017-2022)
    Table 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Gastro Esophageal Reflux Disease (GERD) Drug Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Manufacturing Sites and Area Served
    Table 11. Manufacturers Gastro Esophageal Reflux Disease (GERD) Drug Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Gastro Esophageal Reflux Disease (GERD) Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastro Esophageal Reflux Disease (GERD) Drug as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2017-2022) & (K Pcs)
    Table 16. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2017-2022)
    Table 17. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2017-2022)
    Table 19. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022) & (K Pcs)
    Table 20. North America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2017-2022)
    Table 21. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country (2017-2022)
    Table 23. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022) & (K Pcs)
    Table 24. Europe Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2017-2022)
    Table 25. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales by Region (2017-2022) & (K Pcs)
    Table 28. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022) & (K Pcs)
    Table 32. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2017-2022)
    Table 33. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales by Country (2017-2022) & (K Pcs)
    Table 36. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Country (2017-2022)
    Table 39. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales by Type (2017-2022) & (K Pcs)
    Table 40. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Type (2017-2022)
    Table 41. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Type (2017-2022)
    Table 43. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Type (2017-2022) & (USD/Pcs)
    Table 44. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs) by Application (2017-2022)
    Table 45. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Application (2017-2022)
    Table 46. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Application (2017-2022)
    Table 48. Global Gastro Esophageal Reflux Disease (GERD) Drug Price by Application (2017-2022) & (USD/Pcs)
    Table 49. Pfizer Corporation Information
    Table 50. Pfizer Description and Business Overview
    Table 51. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 52. Pfizer Gastro Esophageal Reflux Disease (GERD) Drug Product
    Table 53. Pfizer Recent Developments/Updates
    Table 54. Novartis AG Corporation Information
    Table 55. Novartis AG Description and Business Overview
    Table 56. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 57. Novartis AG Gastro Esophageal Reflux Disease (GERD) Drug Product
    Table 58. Novartis AG Recent Developments/Updates
    Table 59. GlaxoSmithKline Corporation Information
    Table 60. GlaxoSmithKline Description and Business Overview
    Table 61. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 62. GlaxoSmithKline Gastro Esophageal Reflux Disease (GERD) Drug Product
    Table 63. GlaxoSmithKline Recent Developments/Updates
    Table 64. Merck Corporation Information
    Table 65. Merck Description and Business Overview
    Table 66. Merck Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 67. Merck Gastro Esophageal Reflux Disease (GERD) Drug Product
    Table 68. Merck Recent Developments/Updates
    Table 69. Medtronic Corporation Information
    Table 70. Medtronic Description and Business Overview
    Table 71. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 72. Medtronic Gastro Esophageal Reflux Disease (GERD) Drug Product
    Table 73. Medtronic Recent Developments/Updates
    Table 74. The Kroger Co. Corporation Information
    Table 75. The Kroger Co. Description and Business Overview
    Table 76. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 77. The Kroger Co. Gastro Esophageal Reflux Disease (GERD) Drug Product
    Table 78. The Kroger Co. Recent Developments/Updates
    Table 79. Aros Pharma Corporation Information
    Table 80. Aros Pharma Description and Business Overview
    Table 81. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 82. Aros Pharma Gastro Esophageal Reflux Disease (GERD) Drug Product
    Table 83. Aros Pharma Recent Developments/Updates
    Table 84. AstraZeneca, Plc. Corporation Information
    Table 85. AstraZeneca, Plc. Description and Business Overview
    Table 86. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 87. AstraZeneca, Plc. Gastro Esophageal Reflux Disease (GERD) Drug Product
    Table 88. AstraZeneca, Plc. Recent Developments/Updates
    Table 89. Addex Therapeutics Corporation Information
    Table 90. Addex Therapeutics Description and Business Overview
    Table 91. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 92. Addex Therapeutics Gastro Esophageal Reflux Disease (GERD) Drug Product
    Table 93. Addex Therapeutics Recent Developments/Updates
    Table 94. Takeda Pharmaceutical Company Limited Corporation Information
    Table 95. Takeda Pharmaceutical Company Limited Description and Business Overview
    Table 96. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
    Table 97. Takeda Pharmaceutical Company Limited Gastro Esophageal Reflux Disease (GERD) Drug Product
    Table 98. Takeda Pharmaceutical Company Limited Recent Developments/Updates
    Table 99. Production Base and Market Concentration Rate of Raw Material
    Table 100. Key Suppliers of Raw Materials
    Table 101. Gastro Esophageal Reflux Disease (GERD) Drug Distributors List
    Table 102. Gastro Esophageal Reflux Disease (GERD) Drug Customers List
    Table 103. Gastro Esophageal Reflux Disease (GERD) Drug Market Trends
    Table 104. Gastro Esophageal Reflux Disease (GERD) Drug Market Drivers
    Table 105. Gastro Esophageal Reflux Disease (GERD) Drug Market Challenges
    Table 106. Gastro Esophageal Reflux Disease (GERD) Drug Market Restraints
    Table 107. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 108. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Forecast by Type (2023-2028)
    Table 109. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 110. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 111. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 112. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Forecast by Application (2023-2028)
    Table 113. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 114. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 115. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 116. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share Forecast by Region (2023-2028)
    Table 117. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 118. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Gastro Esophageal Reflux Disease (GERD) Drug
    Figure 2. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Type in 2021 & 2028
    Figure 3. H2 Receptor Antagonist Product Picture
    Figure 4. Proton Pump Inhibitor (PPi) Product Picture
    Figure 5. Antacids Product Picture
    Figure 6. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Application in 2021 & 2028
    Figure 7. Hospital
    Figure 8. Clinic
    Figure 9. Medical Center
    Figure 10. Others
    Figure 11. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Gastro Esophageal Reflux Disease (GERD) Drug Market Size (2017-2028) & (US$ Million)
    Figure 13. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales (2017-2028) & (K Pcs)
    Figure 14. Gastro Esophageal Reflux Disease (GERD) Drug Sales Share by Manufacturers in 2021
    Figure 15. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest Gastro Esophageal Reflux Disease (GERD) Drug Players: Market Share by Revenue in 2021
    Figure 17. Gastro Esophageal Reflux Disease (GERD) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region (2017-2022)
    Figure 19. Global Gastro Esophageal Reflux Disease (GERD) Drug Sales Market Share by Region in 2021
    Figure 20. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region (2017-2022)
    Figure 21. Global Gastro Esophageal Reflux Disease (GERD) Drug Revenue Market Share by Region in 2021
    Figure 22. U.S. Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Taiwan Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Philippines Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Vietnam Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Mexico Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Brazil Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Argentina Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Turkey Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Saudi Arabia Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. U.A.E Gastro Esophageal Reflux Disease (GERD) Drug Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 46. Sales Market Share of Gastro Esophageal Reflux Disease (GERD) Drug by Type (2017-2022)
    Figure 47. Manufacturing Cost Structure of Gastro Esophageal Reflux Disease (GERD) Drug
    Figure 48. Manufacturing Process Analysis of Gastro Esophageal Reflux Disease (GERD) Drug
    Figure 49. Gastro Esophageal Reflux Disease (GERD) Drug Industrial Chain Analysis
    Figure 50. Channels of Distribution
    Figure 51. Distributors Profiles
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis AG
GlaxoSmithKline
Merck
Medtronic
The Kroger Co.
Aros Pharma
AstraZeneca, Plc.
Addex Therapeutics
Takeda Pharmaceutical Company Limited
Frequently Asked Questions
Gastro Esophageal Reflux Disease (GERD) Drug report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gastro Esophageal Reflux Disease (GERD) Drug report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gastro Esophageal Reflux Disease (GERD) Drug report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Patella Prosthesis

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More